90 related articles for article (PubMed ID: 19204178)
1. RALT specifically halts maladaptive cardiac hypertrophy: a new kid on the block.
Bergmann MW; Zelarayan L
Hypertension; 2009 Mar; 53(3):454-5. PubMed ID: 19204178
[No Abstract] [Full Text] [Related]
2. Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling.
Cai J; Yi FF; Yang L; Shen DF; Yang Q; Li A; Ghosh AK; Bian ZY; Yan L; Tang QZ; Li H; Yang XC
Hypertension; 2009 Mar; 53(3):539-48. PubMed ID: 19204184
[TBL] [Abstract][Full Text] [Related]
3. The role of microRNA-133 in cardiac hypertrophy uncovered.
Abdellatif M
Circ Res; 2010 Jan; 106(1):16-8. PubMed ID: 20056941
[No Abstract] [Full Text] [Related]
4. NF-kappaB activation is required for adaptive cardiac hypertrophy.
Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
[TBL] [Abstract][Full Text] [Related]
6. β-MyHC and cardiac hypertrophy: size does matter.
Pandya K; Smithies O
Circ Res; 2011 Sep; 109(6):609-10. PubMed ID: 21885833
[No Abstract] [Full Text] [Related]
7. Enigma in cardiac hypertrophy.
Lompré AM
Cardiovasc Res; 2010 Jun; 86(3):349-50. PubMed ID: 20332097
[No Abstract] [Full Text] [Related]
8. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy.
Nebigil CG; Jaffré F; Messaddeq N; Hickel P; Monassier L; Launay JM; Maroteaux L
Circulation; 2003 Jul; 107(25):3223-9. PubMed ID: 12810613
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
[TBL] [Abstract][Full Text] [Related]
11. Control of stress-dependent cardiac growth and gene expression by a microRNA.
van Rooij E; Sutherland LB; Qi X; Richardson JA; Hill J; Olson EN
Science; 2007 Apr; 316(5824):575-9. PubMed ID: 17379774
[TBL] [Abstract][Full Text] [Related]
12. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
14. Cardiac hypertrophy and the Wnt/Frizzled pathway.
Cingolani OH
Hypertension; 2007 Mar; 49(3):427-8. PubMed ID: 17210831
[No Abstract] [Full Text] [Related]
15. The mAKAP signalosome and cardiac myocyte hypertrophy.
Bauman AL; Michel JJ; Henson E; Dodge-Kafka KL; Kapiloff MS
IUBMB Life; 2007 Mar; 59(3):163-9. PubMed ID: 17487687
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms regarding potassium bromate‑induced cardiac hypertrophy without apoptosis in H9c2 cells.
Kuo SC; Li Y; Cheng YZ; Lee WJ; Cheng JT; Cheng KC
Mol Med Rep; 2018 Nov; 18(5):4700-4708. PubMed ID: 30221729
[TBL] [Abstract][Full Text] [Related]
17. [Proteomic identification of the new functional proteins in the EGF receptor-mediated signaling pathway].
Konishi H
Seikagaku; 2007 Aug; 79(8):781-5. PubMed ID: 17877025
[No Abstract] [Full Text] [Related]
18. The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity.
Anastasi S; Baietti MF; Frosi Y; Alemà S; Segatto O
Oncogene; 2007 Dec; 26(57):7833-46. PubMed ID: 17599051
[TBL] [Abstract][Full Text] [Related]
19. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
[TBL] [Abstract][Full Text] [Related]
20. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling.
Pare GC; Bauman AL; McHenry M; Michel JJ; Dodge-Kafka KL; Kapiloff MS
J Cell Sci; 2005 Dec; 118(Pt 23):5637-46. PubMed ID: 16306226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
